---
$id: https://graph.org.ai/products/commodity/51361809
$type: Product
source: UNSPSC
code: "51361809"
title: "Dexmedetomidine hydrochloride"
class: "51361800"
classTitle: "Hypnotic azoles"
family: "51360000"
familyTitle: "Hypnotics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Dexmedetomidine hydrochloride

**UNSPSC Code**: 51361809
**Class**: [Hypnotic azoles](Hypnotic azoles.mdx)
**Family**: [Hypnotics](../Hypnotics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an alpha-adrenergic agonist with the molecular formula C13H16N2.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1018WH7F9I, chemically known as 1h-imidazole, 4-(1-(2,3-dimethylphenyl)ethyl)-, monohydrochloride, (+-)- but more generally known as dexmedetomidine hydrochloride, which bears US NIH Compound Identifier 68601. European Medicines Agency schedules Dexmedetomidine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB20317. Most nations, for tariff and trade purposes, schedule dexmedetomidine hydrochloride under HS 29332990 and SITC 51573. As of Q4 2014, DEXMEDETOMIDINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Dexmedetomidine hydrochloride bears US NLM identifiers UMLS ID C0876757 and NCI Concept Code C72738. SMILES: CC1CCCC(C1C)[C@H](C)C2C[NH]CN2.CL.

